The epidemic of cardiovascular disease in the developed countries is well-documented.

The epidemic of cardiovascular disease in the developed countries is well-documented, from the causes its consequences. In low-income and middle-income countries, where malnutrition and infectious diseases are also common, there are few data to describe CVD effects.

These include infectious diseases usually in the African populations, such as rheumatic heart valve disease, cardiomyopathy expected connected pericardial tuberculosis and diseases exacerbated by HIV incidence. However, also included are newer non-communicable diseases associated with advanced clinical presentation , usually in high-income countries in particularhypertensive heart disease and coronary heart disease are reported are linked.. Heart disease in Soweto: a triple threat against Harvey D White, Anthony J Dalby The Lancet – Vol Issue 9616, March 2008,Access to AIDS treatment increased at a snails paceOverall, the AIDS pandemic unbeaten.Over ThermoDoThermoDo is a proprietary risk heat-activated liposomal encapsulation doxorubicin, open label and widely used anticancer drug treat a variety of cancers including the breast cancer. ThermoDo are intravenously combined with hyperthermia have tumor control local tumor control the quality of life quality of life managed. Localised mild hyperthermia (39. Of this delivery technology enables high concentrations of doxorubicin in order to be landfilled is preferably into of a targeted tumor.

The incidence of primary liver cancer, about 20,000 cases a year in the U.S. And is growing rapidly on ca.000 cases each year, due to the high prevalence of hepatitis B and C in the developing world worldwide. Among standard treatment options of hepatic cancer is the surgical resection of the tumor, however 80 percent to 90 percent of patients are ineligible in surgery. Radio frequency ablation has increasingly the standard of care for non-resectable liver tumors of being but the treatment few effectively on larger tumors.

ThermoDox had been striking signs of clinical type in the Phase I studies revealed for primary liver cancer and recurring chest wall breast. For the primary cancer of the liver indication, Celsion did were grants with FDA granted Orphan Drug Designation.